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Abstract
Background: With the advancement of biomedical technology, artificial materials have been developed to replace diseased,
damaged or nonfunctional body parts. Among such materials, ultra high molecular weight alkane or modified alkyl
polymers have been extensively used in heart valves, stents, pacemakers, ear implants, as well as total joint replacement
devices. Although much research has been undertaken to design the most non-reactive biologically inert polyethylene
derivatives, strong inflammatory responses followed by rejection and failure of the implant have been noted.
Methodology/Principal Findings: Purification of the alkane polymers from the site of inflammation revealed extensive ‘‘in
vivo’’ oxidation as detected by fourier transformed infra-red spectroscopy. Herein, we report the novel observation that
oxidized alkane polymers induced activation of TLR1/2 pathway as determined by ligand dependent changes in intrinsic
tyrosine fluorescence intensity and NF-kB luciferase gene assays. Oxidized polymers were very effective in activating
dendritic cells and inducing secretion of pro-inflammatory cytokines. Molecular docking of the oxidized alkanes designated
ligand specificity and polymeric conformations fitting into the TLR1/2 binding grooves.
Conclusion/Significance: This is the first report of a synthetic polymer activating immune responses through TLR binding.
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Introduction
With the advancement of biomedical technology, artificial
materials have been developed to replace diseased, damaged or
nonfunctional body parts. Among such materials, ultra high
molecular weight alkane or modified alkyl polymers (PE) have
been extensively used in heart valves, stents, pacemakers, ear
implants, as well as total joint replacement devices [1]. Based upon
the most recent epidemiological data approximately three quarters
of a million joint replacements were performed in the United
States in 2005. Ten to fifteen percent of these joint replacements
were classified as revision joint replacements due to implant
failure. The single most common cause of failure and reason for
revision is a process known as osteolysis [2]. Over time different
size particles and short polymers of wear debris are generated from
the PE implant [3–8]. These micron-size particles as well as low
molecular weight alkane polymers are responsible for the initiation
of an aseptic inflammatory response known as osteolysis [5,9],[2].
The generation of implant-derived wear particles/polymers
prompts an inflammatory reaction at the prosthesis-bone interface
resulting in osteoclastic bone resorption around the implant and
ultimately the mechanical failure of the device. The molecular
mechanisms underlying these clinically important events are very
poorly understood. There is a consensus in the literature that the
size of the particles is important in determining the extent of the
inflammatory process [10]. In particular it appears that smaller
size particles (in the nanometer, micrometer range) which can be
phagocyted by local and recruited antigen presenting cells are the
most likely to cause the initial inflammation [10]. It has also been
reported that macrophages and osteoclast upon phagocytosis of
ultra high molecular weight polyethylene became activated and
mounted a strong pro-inflammatory immune response mediated
by TNF-a, IL1 and IL6 production [5]. However, the molecular
basis for PE recognition by the immune system is not yet known.
Results
Histological evaluation of periprosthetic implant associated
tissue, retrieved from patients undergoing hip replacement surgery
due to PE induced osteolysis, indicated chronic inflammatory
infiltrates (Figure 1a). Immunophenotyping demonstrated that
these infiltrates consisted predominantly of CD68
+ macrophages
(MW), with few T and B cell infiltrates (Figure 1a). Histiocytes and
foreign body giant cells engulfing birefringent PE particles,
generated by wear and tear of the polymeric implant, were also
observed (Figure 1b).
Ultrastructural analysis revealed the presence of micron and sub-
micron PE particles in the periprosthetic inflamed tissue (Figure 1c),
similar to the one derived from chemically synthesized carbonyl
modified alkane polymers (Figure 1d). Micron size PE particles were
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1f). Sub-micron PE particles on the other hand were phagocytosed
by local antigen presenting cells (Figure 1g and 1h).
The presence of PE material at the site of inflammation raised
the question of the molecular basis for alkane polymers recognition
by the immune system. As initial analysis, a biophysical evaluation
by fourier transformed infra-red spectroscopic (FTIR) [11] was
performed on pre and post-implant material to determine possible
alkane polymer modification that could explain the loss of its bio-
inert properties (Figure 2). Analysis was performed on (i) pre-
implant PE, corresponding to the actual biological implant before
surgery, and (ii) post-implant PE, which was retrieved from the site
of osteolysis at the time of revision surgery (Figure 2a and 2b).
Post-implant material was purified according to scheme reported
in Figure 2a. Lipid, sterols and protein analysis determined that
the preparation was void of detectable contaminants as previously
reported [8] (FTMS analysis and assignment of molecular
formulas further confirm purity from lipids and protein contam-
inants (Figure 3a).
FTIR signature peaks at 2900–2800 cm
21 wave numbers
showed the asymmetric stretch of the alkane backbone and a
skeletal vibration of the same backbone was registered at 715
cm
21 for all the four samples. The alkane backbone also exhibited
a predicted deformation at around 1470 m
21 in each case.
Differences in spectra were noted between the pre and post
implant PE material. A dramatic increase in the amount of
carbonyl (carboxylic, ketonic, aldehydic and ester), amide and
alcohol groups was observed in PE polymers prepared from post-
implant material (Figure 2b). The increase in the amount of
carbonyl groups (236% Figure 2c) is due to an ‘‘in situ’’ oxidative
process. This oxidative process may be mediated by enzymes
released from activated DC, MW and osteoclasts, or may occur in
the endosomal compartment of local antigen presenting cells
engorged with PE polymers (Figure 1g, 1h).
To further define the molecular composition of the alkane
polymers retrieved from the post-implant material a Fourier
transform ion cyclotron mass spectroscopy FT/MS in MALDI
(matrix assisted laser desorption ionization) mode was performed.
FT/MS is so far the most sophisticated technique to identify
molecular composition since it combines the most advanced Ion
Trap and Fourier Transform Ion Cyclotron Resonance technol-
ogies into a single instrument with unprecedented analytical
power. Ultra-high resolution and sensitivity coupled with sub mass
prediction accuracy allow determining elemental composition.
Post-implant material was obtained as described in Figure 2b and
short chain alkane polymers were further purified from the nano
and micron size PE particles by centrifugation through a 10,000
membrane cut-off. Pre-implant material was similarly prepared.
FTMS analysis indicated the presence of several small sized PE
polymers in the post-implant material with a molecular mass of
400 to 2000 (Figure 3a). Differently from the pre-implant PE,
where a clear polymer-associated envelope was observed, in the
post implant material this signature was lost due to extensive
oxidation. Chemical formulas were assigned for each molecular
species observed in the post-implant PE. Assignment of each pick
was consistent with an alkane structure back bone bearing several
side chain modifications (Figure 3a). None of the assigned formulas
Figure 1. Periprosthetic inflammatory reaction to micron and
sub-micron size modified n-alkane polymers. a) Immunohisto-
chemistry of periprosthetic tissue retrieved at the time of the implant
revision surgery (20X magnification and 40X for inset). The tissue was
stained with: hematoxylin and eosin to detect total cell infiltrates, CD3
to detect T cells, CD20 to detect B cells and CD68 to detect
macrophages. PE polymers of varied shapes and sizes are visualized
as transparent areas. b) Hematoxylin and eosin staining (right) and
CD68 (left) showing a multi-nucleated giant cell surrounding a large PE
particle. c and d) Electron micrograph of sub micrometer PE particles
c) purified from periprosthetic tissue or d) chemically synthesized mPE
particles shown as control. e, f, g and h) Electron micrograph of
periprosthetic tissue obtained from implant failure prosthesis. e and f)
PE particles are visualized as black material indicated by red arrows. g
and h) PE sub-micron particles, indicated by red arrows, phagocyted by
local antigen presenting cells. A complete engorgement of the
endocytic tract by post implant PE is observed in h.
doi:10.1371/journal.pone.0002438.g001
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PLoS ONE | www.plosone.org 2 June 2008 | Volume 3 | Issue 6 | e2438Figure 2. Modified alkane polymers purified from periprosthetic material increase their number of carbonyl groups. a) Purification
scheme of post implant PE. Optical density of the preparation was measured at different relevant wavelengths at a PE concentration of 100 mg/ml.
Bradford, lipid and sterol assays were also performed using100 ug/ml post-implant PE material. b) Fourier transformed infra-red spectroscopic (FTIR)
analysis pre-implant (new polyethylene implant) and post-implant PE (polyethylene material purified from the site of osteolysis). The analysis was
carried out between 4000 and 500 cm
21 wave number. b) Tabular representation of the prominent peaks (cm
21), and the predicted bonds with the
relevant vibrational modes for pre-implant and post-implant PE. Integral intensities are given for each prominent peak. c) Total integral intensity of
alkane and carbonyl groups in pre and post-implant material. Ratio between the two groups is shown.
doi:10.1371/journal.pone.0002438.g002
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PLoS ONE | www.plosone.org 3 June 2008 | Volume 3 | Issue 6 | e2438Figure 3. Mass spectroscopy analysis of n-alkane polymers purified from post implant PE indicates extensive oxidation. a) Fourier
transformed FT/MS-MALDI analysis of pre and post implant PE polymers (molecular mass ranging between 400 and 2000). b) Predicted chemical
composition for major peaks of post implant PE derived from FT-MS analysis depicted in a. c) MALDI-TOF scan (600–900 m/z) of PE purified from
post-implant PE and mPE. d) Predicted chemical composition for major peaks of mPE and post implant PE depicted in c.
doi:10.1371/journal.pone.0002438.g003
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or lipopeptides further confirming the purity of the post-implant
preparation. Most of the high molecular weight alkane polymers
presented extensive addition of carboxyl groups (Figure 3b and
Figure S1). In the lower molecular weight mass several polymers
could be observed with a low degree of oxidation similar to the MS/
MS profile, of mPE polymers (chemically synthesized PE polymers
with few side chain modifications (hydroxyl and carboxyl functional
groups)(Figure 3c and 3d and Figure S2). In bothsamples two major
clusters of peaks in the 600 and 800 mass range could be observed
(Figure 3c). Further analysis by TOF-TOF MALDI [12] fragmen-
tation indicated an identical fragmentation pattern for both mPE
and postimplantPE.Inbothcasesthe617peakfragmentedinto428
and 572 m/z, while the 806 peak fragmented into 617 (Figure S3).
We therefore concluded that polymers of different sizes and amount
of oxidation were present at the site of inflammation associated with
as t r o n gi n n a t ei m m u n er e s p o n s e .
The observation of modified PE material at the site of
inflammation associated with cellular infiltrates prompted us to
evaluate whether exposure to the modified polymers would activate
antigen presenting cells. To test for this, we used pre-implant PE,
post-implant PE, and chemically synthesized PE polymers without
(unPE) or with side chain modification (hydroxyl and carboxyl
functional groups) (mPE) matching several of the modification
observed in the post-implant PE (Figure 3c). Dendritic cells (DC)
cultured for 48 hours in the presence of 50 mg/ml of eachcompound
were evaluated for surface MHC class II expression. An up-
regulation of MHC class II molecules was observed in post-implant
and mPE treated cells only, to level similar to what observed with the
lipopeptide Pam2CSK4 (Figure 4a, 4b). DC activation was further
confirmed by a significant increase in IL-12 secretion determined by
ELISA (Figure 4c). We concluded that the hydroxyl and carboxyl
modified mPE polymers and post-implant PE can interact with DC
and initiate an inflammatory response.
A strong and rapid initiation and activation of the innate
immune response is generally achieved through engagement of
members of the toll like receptor (TLR) family [13,14]. Hence, we
investigated further whether any of the TLRs were actually
involved in the recognition of the mPE as well as post-implant
modified alkane polymers. Human 3T3 HEK cell lines stably
expressing TLR1/2, TLR2, TLR3 and TLR4 genes respectively
were transfected with a plasmid encoding the luciferase reporter
gene under the control of the NF-kB enhancer element. Thus, NF-
kB activation by pro-inflammatory stimuli would, in turn, up-
regulate luciferase production. Each TLR cell line was assayed for
activation with different PE preparations, chemically synthesized
(unPE and mPE) or alkane polymers prepared from the pre implant
and post implant material [8]. Each assay also included a well
known specific positive ligand for each respective TLR (Figure 5).
Both mPE and post-implant preparations induced luciferase up-
regulation in both TLR1/2 and TLR2 transfectants, but not in the
TLR3 and TLR4 cell lines (Figure 5). Thus, we conclude that the
carbonyl modified PE polymers cause a strong activation of the
innate immune system and initiate an inflammatory cascade
through the TLR1/2 receptor activation pathway.
To further analyze the TLR2 binding activity of modified
alkane polymers a soluble form of human recombinant TLR2
(extracellular domain Glu 21-Leu 590) was utilized in a binding
assay that monitored changes in fluorescence intensity (lexcitation
=277 nm and lemission=335 nm) of a tyrosine present in the
TLR2 binding grove (Tyr 326) [15]. Changes in the binding grove
environment, due to ligand occupancy would change the Tyr
fluorescence intensity and the wavelength of its fluorescence
emission. Soluble TLR-2 was incubated with increasing concen-
trations of each polyethylene derivatives; mPE (as a mixture of
hydroxyl and ester bond alkane polymers), PE (unmodified alkane
polymers) pre and post implant PE and the positive control,
Pam2CSK4 lipopeptide (known to be a specific ligand for TLR-2)
[15]. The emission scans (between 290 and 420 nm) were collected
for each complex separately and the change in maximum
fluorescence signal at 335 nm (due to tyrosinate ion) was used to
generate the binding curves, after subtracting the contribution of
the free protein (in the absence of any compounds). The
normalized fluorescence data were fitted to a hyperbolic function
using the software GraphPad Prism 4 (Figure 6).
The steady-state intrinsic fluorescence emission of TLR-2
strongly increased to ligand saturability upon the addition of
mPE. Since mPE comprise a random mixture of hydroxyl and
carboxyl alkanes (Figure S2) a binding Kd was calculated for both
components. For hydroxyl and carboxyl modified alkanes the
Figure 4. Modified alkane polymers induce DC activation and IL-
12 secretion. a) FACS analysis of DC untreated or treated for 48 hours
with unPE, mPE, pre and post implant alkane polymers. Surface staining
was performed with antibodies to MHC class II molecules, Data are shown
as increase in MFI as compared to the untreated control. b) Histograms
overlay of MHC class II staining in DC untreated or treated with different
concentrations of unPE and mPE. c) Elisa for IL-12 present in the
supernatant of DC untreated or treated for 48 hours with unPE, mPE, pre
and post implant alkane polymers (data are expressed in pg/ml).
doi:10.1371/journal.pone.0002438.g004
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Thus, the predicted Kd range for the modified alkane mixture was
veryclosetothe Pam2CSK4 positivecontrol(Figure6).Importantly,
the alkane binding to soluble TLR-2 was inhibited following
incubation with the monoclonal antibody anti human TLR2 (clone
383936 R&D Systems) which is known to prevent ligand access to
the TLR2 binding groove [16]. On the other hand the affinity of
binding for non-modified alkane polymers (unPE) and pre-implant
materialwasmuchlowerthan the one reportedfor theoxidized ones
(Figure 6). Post-implant PE, a wide mixture of non-oxidized and
oxidized alkanes also showed a saturable binding even though the
blend of different alkane species did not allow for Kd mesurement to
be calculated. Nevertheless, the binding was completely blocked by
addition of the TLR2 mAb (Figure 6). In general a positive
correlation was observed between TLR2 binding affinity and
amount of oxidation of the alkane polymeric structures (Figure 6b)
in agreement with the luciferase assay data (Figure 5).
The crystal structure of TLR1/2 combined with an active
bacterial ligand (Pam3CSK4) indicates that the CH2 backbone of
the lipid ligand occupies the three hydrophobic active pockets
[15]. Since FTIR analysis indicated that in the post-implant
material alkane oxidation was the prevalent modification of the
alkane groups we further characterize the interaction between the
oxidized alkane polymers and TLR1/2 receptors. The structural
fitness of; (i) a 24 repetitive units of an alcohol modified alkane
polymer (1390 m/z), (ii) its oxidized form (1406 m/z), (iii) and an
isomer from a post-implant polymer (1333 m/z) into the binding
site of TLR-1/2 were evaluated. Molecular docking was
performed using as template the 2z7x.pdb structure of the TLR-
1/2 in complex with the tri-acylated lipopeptide Pam3CSk4 [15]
(Figure 7). The mPE and post-implant polymers were designed to
have an m/z ratio extrapolated from the FT/MS data (Figure 3a
and Figure S2) and all the polymers had at least 16 carbons in their
backbone based on published structural requirements for a
TLR1/2 ligand [17]. The polymer structures were merged into
the X-Ray structure 2z7x.pdb, such that each individual polymer
was superimposed over the original ligand Pam3CSK4. The Pam
ligand was then deleted to generate the TLR1/2-mPE complex
(Figure 7a). The relative free energy of interaction between each of
the new ligands and the TLR1/2 heterodimer was assessed using
the MM94FF force field built-in the software SCULPT. Both the
hydroxyl-modified alkane (mPE-1390) and the carboxyl form
(mPE-1406) as well as the post implant 1333 were predicted to be
very good fit based on the relative free energy of interaction as
compared to the Pam3CSK4-lipopeptide control (Figure 7b).
Thus, additional structural analysis of the interaction between
mPE-1390 and TLR1/2 was performed by extracting the amino
acids from the binding pocket of the receptor which made contacts
with the ligand (Figure 7c). Altogether, the predicted relative free
energy of binding, as determined by Vander waals and
electrostatic interactions (kcal/mol), together with the analysis of
amino acids contacts between the ligand and the receptor clearly
indicated a strong probability for hydroxyl-modified alkane
polymers to fit appropriately into the TLR1/2 binding groove.
Discussion
Our study shows for the first time that organic synthetic
polymers with an alkane subunit backbone and different carbonyl/
amide side chain modifications can act as potent TLR2 and
TLR1/2 activators.
It has been previously reported that extensive damage occurs in
implanted akane polymeric structures in particular at sites of
weight bearing. The process of PE breakdown generates
Figure 5. Modified alkane polymers induce activation of TLR-1 and TLR-2 signaling pathways. a) Luciferase activity expressed by human
TLR1/2, TLR2, TLR3 and TLR4 stable HEK 3T3 transfectant (pNF-kB-LUC Stratagene). Cells were left untreated or treated for a different time period with
50 mg/ml of unPE, mPE or pre and post implant PE and respective positive controls; PGN(10 mg/ml) for TLR1/2 and TLR2, Poly (I:C)(1 mg/ml) for TLR3
and LPS (10 mg/ml) for TLR4.
doi:10.1371/journal.pone.0002438.g005
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PLoS ONE | www.plosone.org 6 June 2008 | Volume 3 | Issue 6 | e2438Figure 6. Direct binding of oxidized alkane polymers to soluble TLR-2 molecules. a) Left panels; fluorescence emission scans collected for
free soluble TLR2 and TLR2 in complex with two different concentrations (exponential and plateau) of each analyzed polymer. Central panels;
normalized fluorescence data (DF) for each concentration point as a function of the free ligand concentration. Right panels; fluorescence emission
scans collected for free soluble TLR2 and TLR2 in complex with each analyzed polymer at two different concentrations (exponential and plateau) in
presence of an anti TLR2 mAb known to block the TLR2 binding groove (stoichiometric ratio 2:1 Ab to soluble TLR2 receptor). b) Comparison of the
fluorescence emission scans collected for soluble TLR2, mPE and unPE.
doi:10.1371/journal.pone.0002438.g006
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the peri-implant tissue as well as in endosomal compartment of
resident osteoclast and macrophages [3–10,18,19]. Herein, we also
identify alkane polymers as additional products of PE breakdown.
Interaction between PE particles/polymers and the host cells leads
to oxidative changes by means of enzymatic, extracellular matrix-
degrading activity of cells that have phagocytosed them or adhered
to them. Under hyper-oxidative conditions and in presence of
many enzymatic complexes, among which lipooxygenases, the free
radicals could react fast with oxygen giving peroxide ROON
Figure 7. Mass spectroscopy analysis of n-alkane polymers predicted conformations fitting within the hydrophobic pocket of TLR-
1/TLR-2 receptor. a) Docking and predicted conformations for the 1390 and 1406 mPE fragments and 1333 post implant PE fragment. b) Predicted
relative free energies of interaction between the ligands reported in a and the TLR-1/TLR-2 receptor determined with the MM94FF force field. c)
Amino-acids within the binding site of TLR-1/TLR-2 that are making contacts with the ligands Pam (from the original 2z7x.pdb structure) and with the
mPE ligand (mPE-1390).
doi:10.1371/journal.pone.0002438.g007
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PLoS ONE | www.plosone.org 8 June 2008 | Volume 3 | Issue 6 | e2438radicals and generate different alkane polymers with aldehyde,
ketonic and hydroxyl groups as determined by FTIR, and FTMS
(Figure 2 and 3). On the other hand the free polymeric radicals
could re-react by cross linking each other and regenerate a
saturated polymeric structure as well as formation of unsaturated
structures with double bonds; both modifications were observed by
FTMS (Figure 2 and 3). Altogether our data indicate that the PE
breakdown and oxidation process released several carbonyl-
modified alkane polymers with carbon chains of different length
in the periprosthetic tissue.
Toll like receptors (TLR) are important pattern recognition
receptors of the innate immune system. Among those TLR 2 is
responsible for the functional recognition of lipoproteins/peptide
constituent of the cell wall of bacteria [13,14,17,20,21]. TLR2 is
different from other TLRs in that it is also activated by heterotypic
interactions with TLR1 and TLR6. It was generally accepted that
tryacylated lipopeptides are recognized by TLR1/TLR2, whereas
dyacylated lipopeptides are recognized by TLR2/TLR6 [21]. Such
dogma was recently challenged by reports that dyacylated lipopep-
tide could engage TLR2 in a TLR6 independent manner raising the
possibility that TLR2 might be able to signal as homomers [20].
Recent analysis of the structural requirements for optimal TLR2
ligands was performed and indicated that two ester bond fatty acids
with at least 12 carbon atoms were required to stimulate a cellular
response [17]. In contrast, amide-bound fatty acids had no
remarkable effect on TLR2 recognition even though they could
determine the co-receptor usage (TLR1 vs. TLR6) [17].
Herein, a thorough biophysical analysis determined that the post
implant PE retrieved at the site of inflammation encompass different
carbon chain length alkane polymers modified by the addition of
carboxyl groups. The mixtureoftheoxidized polymers werecapable
of activating TLR2 and TLR1/2 transfectant only few folds above
the range of activation observed with the pre-implant material. This
result has to be interpreted in light of the fact that several alkane
species are present in the peri-implant tissue bearing different
degrees of modification and carbon chain length, obviously not all of
them compatible with TLR1/2 engagement. However, the
requirement of alkane oxidation was further confirmed using
chemically synthesized PE alkane with or without hydroxyl and
carboxyl groups. Using this controlled in vitro system we could
determine that carboxyl-modified alkanes were able to engage a
soluble TLR2 with a 140 times greater binding affinity as compared
to the non oxidized polymers. Molecular docking further confirmed
that mPE polymers avidly fit into the hydrophobic groove of the
TLR1/2 heterodimeric crystal structure.
Altogether our results show that the strong immune reaction
following the break down of PE implant can be attributed to
TLR1/2 engagement. This results can provide the molecular basis
for the strong macrophages, osteoclasts and granulocytes activa-
tion observed at the site of the implant as well as after in vitro
treatment with PE generated polymers [2–10,18,19,22–29].
Important implications can be drawn for designing n-alkane/
alkenes polymeric compounds with similar bio-performance but
reduced immunogenecity.
Materials and Methods
Polyethylene
Ultra high molecular weight polyethylene unmodified (unPE)
and carbonyl modified (mPE) were purchased from Sigma (cat#
429015 and # 434272 respectively). Both forms were prepared at
20 mg/ml in PBS and added in culture media at different amounts
as reported in each figure legend. In some experiments a 10,000
MW cut off of PE preparations was utilized to test for the presence
of shorter polymers. Post implant PE particles and polymers were
purified from peri-prosthetic tissue removed at the time of the hip
or knee revision surgery. All patients were diagnosed with
loosening of the implant due to aseptic osteolysis and immune
reaction to PE material. The scheme for PE purification is
presented in Figure 2a as previously published [8].
Immunohistochemistry
Tissue was formalin-fixed and paraffin embedded and cut on a
microtome (4 um). Tissue slides were dried over night at room
temperature, deparaffinize with xylene, cleared with graded
ETOH (100%62, 95%, 70%), and rinsed with ddH2O. Antigen
retrieval was performed by microwave using Citrate buffer pH6.0
at 97o for 10 minutes. Slides were incubated with the following
primary antibodies for 30 minutes: CD20 monoclonal mouse anti-
human (mAb) (clone L26; dilution 1:3000), CD3 polyclonal rabbit
anti-human (#A0452; dilution 1:200), CD68 mAb (clone PGM-1;
dilution 1:25) all from Dako Corp. (Carpinteria, CA). Antigen-
antibody reaction was visualized using diaminobenzidine chromo-
gen (DAB) applied for 7 minutes. Sections were counterstained in
Hematoxylin for 30 seconds, cleared in 2% Glacial acetic acid for
30 seconds, rinsed in hot water then in 0.2% Ammonia Water for
10 seconds, rinsed in water, then dehydrated in ETOH and in
Xylene before manual cover slipping. Samples were analyzed by
light microscopy and polarized light microscopy to identified
birefringent polyethylene particles (PE).
Electron Microscopy
Tissue was fixed with a mixture of 2% paraformaldheyde and
4% PVP in phosphate buffer 0.2 M, pH 7.4 at 4uC and epon
embedded. DCs untreated or treated with mPE for 48 hours were
similarly fixed. Samples were processed for ultra-thin sectioning.
Contrast was obtained with a mixture of 2% methylcellulose
(SIGMA) and 0.4% uranyl acetate pH4 (EMS). Samples were
viewed under a CM120 Philips electron microscope.
Dendritic cells preparation and FACS analysis
Peripheral blood was obtained from the New York Blood Bank.
The CD14+ monocyte population was separated using CD14
conjugated MicroBeads (Miltenyi Biotec). Purified cells were
cultured in GM-CSF/IL4 (30 ng/ml plus 10 ng/ml) (RD Systems)
for 5 to 6 days in DMEM (GIBCO, Grand Island, NY, USA). In
some experiments DC were cultured in presence or absence of
unPE, mPE and pre and post implant PE for 48 hours. DC were
then washed with cold PBS, and labeled for 30 min on ice with
saturating amounts of anti human HLA-DR (clone TU36) (BD
Biosciences, Pharmingen, San Diego, CA) in staining buffer (PBS/
0.1 % BSA/ 0.01% NaN3). The Cells were analyzed using a
FACSCalibur flow cytometer and cellquest software program (BD
Biosciences Mountain View, CA, USA).
ELISA
DC were cultured in presence or absence of unPE, mPE and pre
and post implant PE as described above. Culture supernatant was
collected, filtered through a 20 mm filter and assayed for human
IL-12 (Biosource (Invitrogen) according to the manufacturer
instruction.
Luciferase assay
The HEK 293/TLR clones (Invivogen) were used to determine
TLR1/2, TLR2, TLR3 and TLR4 activation by PE. Each clone
was transfected with the NF-KB cis- reporter enhancer (pNF-kb-
LUC, Stratagene) and an independent GFP containing using
TLR2 and Alkane Polymers
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measured by FACS. Forty-eight hours post transfection the cells
were treated with unPE, mPE, pre and post-implant-PE, as well as
a positive controls; PGN (peptidoglycan from Staphylococcus aureus)
at a concentration of 10 mg/ml l for TLR1/2 and TLR2, Poly
(I:C) (polyinosinic:polycytidylic acid) was used at 1 mg/ml for
TLR3 and LPS (lipopolysaccharide) at a concentration of 10 mg/
ml for TLR4. All the controls were purchased from Invivogen.
The luciferase readout was measured at different time points using
the standard Luciferase reporter assay kit (Promega).
Fourier Transform Infra-red spectroscopic analysis
Pre-implant PE and post-implant PE were analyzed by Fourier
transformed infrared (FTIR) spectroscopy. All FTIR data was
collected using JASCO 6100 Infrared Spectrometer equipped with
a Golden Gate Attenuated Total Reflectance (ATR) cell. In order
to prevent contamination between samples, the ATR window was
cleaned with methanol prior to each analysis. The data were then
analyzed using JASCO’s spectra manager software (BioRad’s
Know it all software and Fiveash Data Management polymer
database.
Equilibrium titrations of polyethylene compounds into
hrTLR-2.
Binding of different polyethylene compounds and of lipopeptide
control Pam2CSK-4 to hrTLR-2 was determined by monitoring
changes in the receptor’s intrinsic tyrosine fluorescence emission.
The steady state fluorescence emission spectra were collected
between 290 and 420 nm using lexcitation=277 nm for tyrosine, 5
nm bandwidth for both emission and excitation wavelengths and a
response time of 0.5 seconds for each scan. Soluble TLR-2 was
titrated with increasing concentrations of each polyethylene
derivatives unPE, mPE, pre and post implant PE and the positive
control, Pam2CSK4 lipopeptide (known to be a specific ligand for
TLR-2 [15]. For each titration assay complexes between TLR-2
and each compound were preformed by incubating the protein (15
or 76 nM) with different compounds at different concentrations in
20 mM Tris-HCl with 200 mM NaCL, pH=8.0 buffer at 4uC for
1 hour. Before reading their fluorescence emission scans between
290 and 420 nm the complexes were equilibrated at room
temperature. The emission scans were collected for each complex
separately and the change in maximum fluorescence signal at 335
nm (due to tyrosinate ions) was used to generate the binding
curves, after subtracting the contribution of the free protein (in the
absence of any compounds). The normalized fluorescence data
were fitted to a hyperbolic function (one single binding site model)
using the software GraphPad Prism 4. Similar experiments were
conducted in presence of mouse anti human TLR2 mAb (clone
383936 R&D Systems) which is known to prevent ligand access to
the TLR2 binding groove. The anti TLR-2 mAb was pre-
incubated with the human recombinant TLR-2 on ice for 30
minutes at a stoichiometric ratio 2:1 (Ab: soluble receptor). Each
binding compounds; unPE, mPE, pre and post implant material
was then added at different concentrations to the preformed
complexes. Emission scans were collected as described above.
Spectroscopic Analysis
Optical density of the pre- and the post-implant were
determined at a concentration of 100 ugm/ml at the relevant
wavelength after proper blanking of the instrument (BioRad smart
spec 3000). The Bradford assay was performed at the identical
concentration using the Biorad Braford assay kit (Biorad #
500006). Protein concentration was determined from the standard
plot. The absence of lipids and the sterol were determined using
the Libermann-Burchard test.
Mass Spectroscopic Analysis
Mass spectroscopic analysis of all PEs samples were performed
using MALDI (matrix assisted laser desorption/ionization) time of
flight (TOF) and MS/MS MALDI-TOF/TOF technologies. Data
were acquired using an ABI-4700 mass analyzer (Applied
Biosystems, Framingham, MA). All spectra were collected in the
reflector mode. Samples were prepared by mixing equal amounts
of matrix (a-cyano-4-hydroxycinnamic acid from Sigma) and
sample, each dissolved in 50% acetonitrile and 50% 0.1%
trifluororacetic acid (TFA). The samples were loaded on a 192
well engraved stainless steel plate (ABI 433375). Calibration was
updated before each acquisition using a standard peptide mixture
according to instrument protocol. The PEs subjected to MS
analysis were pre-filtered through Amicon Centriplus (YM-10,000:
10,000 Da cut-off). Only the filtrates were used for MS analysis.
FT-MS
Mass Spectra were acquired on a Varian Fourier transform
Mass Spectrometer (FTMS) (Lake Forest, CA) equipped with a
MALDI source. The spectra were imported from Varian Doc
Viewer and the analysis of chemical composition of each peak of
interest was performed with the built-in software.
Molecular docking
Molecular docking was carried out using SCULPT ‘‘Interactive
3D Structural and Electronic Analysis’’ software package provided
by MDL Information systems, Inc (San Leandro, CA). The
2z7x.pdb structure of the TLR-1/TLR-2 heterodimers receptor in
complex with the tri-acylated lipopeptide Pam3CSK4 was used as
target while the new PE polymer ligands were derived from the
original structure of the monomer (C3H6O)n predicted by the
Fourier Transformed Mass Spectroscopy (FT-MS) data (supple-
mentary information Sx). The new PEs were drawn in ISIS
DRAW (MDL) and imported into SCULPT superimposing each
structure over the original Pam3CSK4 ligand which was deleted
such that the template TLR1/TLR2 had in its binding groove the
new PEs. During each cycle of minimization the protein was
freezed while the ligand was thawed using the corresponding
functions from the SCULPT software. This rigid docking
procedure ensured the flexible conformational search for the
ligand within the binding site while the protein remained in its
original conformation. The minimization procedures used both
Van der Waals potential for finding the best sterical fit of the
ligand into the binding groove and the electrostatic potential
provided by the MM94FF built-in SCULPT to assess the relative
free energy of binding between the ligand and the target protein.
Supporting Information
Figure S1 Mass spectroscopy analysis of n-alkane polymers
purified from post implant PE indicates extensive oxidation. a)
Predicted chemical composition for major peaks of post implant
PE derived from FT-MS analysis depicted in Figure 3a.
Found at: doi:10.1371/journal.pone.0002438.s001 (0.68 MB TIF)
Figure S2 FTMS analysis of mPE. a) Fourier transformed FT/
MS-MALDI analysis of carboxyl-modified mPE polymers.
Found at: doi:10.1371/journal.pone.0002438.s002 (0.53 MB TIF)
Figure S3 MALDI parent ions 617 and 806 from PE and mPE
have a similar fragmentation pattern. MALDI-TOF-TOF analysis
of precursor ion 617 fragmentation into 428 and 572 for post
TLR2 and Alkane Polymers
PLoS ONE | www.plosone.org 10 June 2008 | Volume 3 | Issue 6 | e2438implant PE and mPE and MALDI-TOF-TOF fragmentation of
precursor ion 808 into 617 for both pPE and mPE.
Found at: doi:10.1371/journal.pone.0002438.s003 (0.52 MB TIF)
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